What are the latest advancements in cancer treatments?

With one in two people being diagnosed with cancer in their lifetime, and 450 people dying from the disease in the UK each day on average, cancer more than any other disease seems to affect each of us in some way or another.

Whilst the facts surrounding the condition aren’t exactly joyous the great work cancer specialists, such as Dr Tobi Arkenau, carry out ensures that we’re continuously breaking new ground in tackling the disease, with innovative new treatments such as immunotherapy providing hope for the future.
Youtube Thumbnail Cancer Treatment Podcast
icnplay

Episode 18: The Future of Cancer Treatment

In episode 18 of HCA UK’s ‘Fact vs Fiction’ health podcast, Anna Richardson talks in-depth about the future of cancer treatment with Dr Tobi Arkenau, consultant oncologist and founding medical director of HCA Healthcare UK’s Sarah Cannon Research Institute.

Listen to The Future of Cancer Treatment on:

Apple podcasts
Google podcasts
Spotify.

 

Things we learn in this episode

Every two minutes someone in the UK is diagnosed with cancer. We have all encountered the Big C – whether we know someone who has been affected or we’ve been diagnosed ourselves. But what’s the future of cancer treatment? And will we ever make it a thing of the past?


Anna Richardson talks about clinical trials and new advances in therapies, such as immunotherapy, with Dr Tobi Arkenau, Consultant Oncologist and Executive Medical Director of HCA Healthcare UK’s Sarah Cannon Research Institute.

Cancer survival rate Fact

Over 160,000 people die of cancer in the UK each year. Tobi explains that despite these daunting figures, survival rates of cancer have increased dramatically in common cancers such as lung, breast and colon cancer.

Cancer treatment Fiction

Chemotherapy and Radiotherapy are the only types of cancer treatments. Tobi talks us through the range of cancer treatments available from surgery through to using your own immune system to treat cancer.

Cancer Fact

Cancer can trick your immune system to ignore it. Tobi says cancer cells can evade the immune system enabling tumours to go undetected and grow.

Cancer clinical trial Fiction

Taking part in a clinical trial is very much a last resort. Tobi tells Anna about trial regulation and why it is important to consider all your treatment options, including clinical trials which are playing an increasing role in cancer treatment.

Useful links from today's cancer treatment show

What to do next

Dr Henrik-Tobias Arkenau

Dr Tobias Arkenau is a Consultant Oncologist and Executive Medical Director of Sarah Cannon Research Institute, part of HCA Healthcare UK.

Dr Arkenau has vast experience in Early Oncology Clinical Drug Development with a special interest in gastrointestinal cancer and melanoma. He received his medical degree in 2000 at the Medical School Hanover, Germany, and completed his internship and specialist training in oncology in 2007. As part of Sarah Cannon’s collaboration with University College London (UCL), Dr Arkenau was appointed as a Professorial Research Associate on UCLs faculty and he holds an Honorary Consultant post with UCL Hospitals.

Dr Arkenau is Fellow of the Royal College of Physicians, and member of The German Cancer Society, ASCO, AACR and ESMO. He has presented multiple talks on the latest research in Oncology and has been an Invited Speaker at several national and international meetings.

Dr Arkenau has published articles in international peer-reviewed journals including The Lancet, J Clin Oncol, Clin Cancer Res, Annals of Oncology and many others and serves as ‘Contributing Associate Editor-in-Chief’ of the World Journal of Gastroenterology and ‘Associate Editor’ of World Journal of Cancer Research.

Contact us

If our podcast topics have inspired you to seek further advice, our team will be happy to make an appointment for you with a consultant. 

Call us on 020 3993 3468
Request an appointment
back to top